{
    "organizations": [],
    "uuid": "c2720280094fed1365e55cced2618d5642732e6b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-moberg-pharma-receives-favorable-o/brief-moberg-pharma-receives-favorable-outcome-from-nad-idUSFWN1PA037",
    "ord_in_thread": 0,
    "title": "BRIEF-Moberg Pharma Receives Favorable Outcome From NAD",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 15 (Reuters) - Moberg Pharma Ab (Publ):\n* MOBERG PHARMA RECEIVES FAVORABLE OUTCOME FROM NAD - MAIN COMPETITOR TO DISCONTINUE CURRENT MARKETING\n* EXPECTS OUTCOME TO FURTHER STRENGTHEN KERASAL NAILSÂ® POSITION AND GROWTH PROSPECTS IN U.S. MARKET Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-15T15:44:00.000+02:00",
    "crawled": "2018-01-16T13:25:15.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "moberg",
        "pharma",
        "ab",
        "publ",
        "moberg",
        "pharma",
        "receives",
        "favorable",
        "outcome",
        "nad",
        "main",
        "competitor",
        "discontinue",
        "current",
        "marketing",
        "expects",
        "outcome",
        "strengthen",
        "kerasal",
        "position",
        "growth",
        "prospect",
        "market",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}